Genedata, a provider of software solutions for drug discovery and life science research, reported that Biopharm R&D at GlaxoSmithKline (GSK) has selected Genedata Biologics as a R&D data management and workflow-support platform. The Genedata Biologics platform will support multiple GSK Biopharm R&D groups including lead identification and screening, protein optimization and engineering, and protein production.
The system can record, manage, and process data from GSK's antibody discovery platforms such as phage and yeast display, hybridoma, and other technologies. Genedata reports that the system can help to improve data quality, improve efficiency through upload and export of instrument data, and increase experimental throughput. Genedata and GSK will work together to support new discovery technologies and next-generation antibody formats.